Khor YH, Ng Y, Barnes H, Goh NSL, McDonald CF, Holland AE. Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review. Eur Respir Rev. 2020;29(157).
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.
Article PubMed PubMed Central Google Scholar
Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44–68.
Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18–47.
Article PubMed PubMed Central Google Scholar
Platenburg M, van Moorsel CHM, Wiertz IA, van der Vis JJ, Vorselaars ADM, Veltkamp M et al. Improved Survival of IPF patients Treated With Antifibrotic Drugs Compared With Untreated Patients. Lung. 2023.
Kolilekas L, Manali E, Vlami KA, Lyberopoulos P, Triantafillidou C, Kagouridis K, et al. Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis. J Clin Sleep Med. 2013;9(6):593–601.
Article PubMed PubMed Central Google Scholar
Lee RN, Kelly E, Nolan G, Eigenheer S, Boylan D, Murphy D, et al. Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers. QJM. 2015;108(4):315–23.
Article CAS PubMed Google Scholar
Bosi M, Milioli G, Fanfulla F, Tomassetti S, Ryu JH, Parrino L, et al. OSA and prolonged Oxygen Desaturation during Sleep are strong predictors of poor outcome in IPF. Lung. 2017;195(5):643–51.
Tudorache V, Traila D, Marc M, Oancea C, Manolescu D, Tudorache E, et al. Impact of moderate to severe obstructive sleep apnea on the cognition in idiopathic pulmonary fibrosis. PLoS ONE. 2019;14(2):e0211455.
Article CAS PubMed PubMed Central Google Scholar
Gille T, Didier M, Boubaya M, Moya L, Sutton A, Carton Z et al. Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis. Eur Respir J. 2017;49(6).
Mermigkis C, Bouloukaki I, Antoniou K, Papadogiannis G, Giannarakis I, Varouchakis G, et al. Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep Breath. 2015;19(1):385–91.
Corte TJ, Wort SJ, Talbot S, Macdonald PM, Hansel DM, Polkey M, et al. Elevated nocturnal desaturation index predicts mortality in interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29(1):41–50.
Troy LK, Young IH, Lau EMT, Wong KKH, Yee BJ, Torzillo PJ, et al. Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease. Respirology. 2019;24(10):996–1004.
Bordas-Martinez J, Salord N, Vicens-Zygmunt V, Perez S, Prado E, Calvo M et al. Characterization of Sleep-Disordered Breathing in Idiopathic Pulmonary Fibrosis. Arch Bronconeumol. 2023.
Hagmeyer L, Herkenrath SD, Treml M, Pietzke-Calcagnile A, Anduleit N, Randerath W. Sleep-related breathing disorders in idiopathic pulmonary fibrosis are frequent and may be associated with pulmonary vascular involvement. Sleep Breath. 2022.
Lederer DJ, Jelic S, Basner RC, Ishizaka A, Bhattacharya J. Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea. Eur Respir J. 2009;33(4):793–6.
Article CAS PubMed PubMed Central Google Scholar
Aihara K, Oga T, Harada Y, Chihara Y, Handa T, Tanizawa K, et al. Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea. Respir Med. 2011;105(6):939–45.
Kim JS, Podolanczuk AJ, Borker P, Kawut SM, Raghu G, Kaufman JD, et al. Obstructive sleep apnea and subclinical interstitial lung disease in the multi-ethnic study of atherosclerosis (MESA). Ann Am Thorac Soc. 2017;14(12):1786–95.
Article PubMed PubMed Central Google Scholar
Bouloukaki I, Fanaridis M, Testelmans D, Pataka A, Schiza S. Overlaps between obstructive sleep apnoea and other respiratory diseases, including COPD, asthma and interstitial lung disease. Breathe (Sheff). 2022;18(3):220073.
Locke BW, Lee JJ, Sundar KM. OSA and Chronic Respiratory Disease: mechanisms and epidemiology. Int J Environ Res Public Health. 2022;19(9).
Mermigkis C, Bouloukaki I, Schiza SE. Sleep as a new target for improving outcomes in idiopathic pulmonary fibrosis. Chest. 2017;152(6):1327–38.
Papadogiannis G, Bouloukaki I, Mermigkis C, Michelakis S, Ermidou C, Mauroudi E, et al. Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment. J Clin Sleep Med. 2021;17(3):533–44.
Article PubMed PubMed Central Google Scholar
Mermigkis C, Bouloukaki I, Antoniou KM, Mermigkis D, Psathakis K, Giannarakis I, et al. CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep? Sleep Breath. 2013;17(4):1137–43.
Mermigkis C, Mermigkis D, Varouchakis G, Schiza S. CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea–therapeutic difficulties and dilemmas. Sleep Breath. 2012;16(1):1–3.
Al Aghbari J, Wong K, Lau E, Taylor N, Webster S, Yee B, et al. Supplemental oxygen improves sleep disordered breathing but not quality of life in patients with interstitial lung disease. Respirol (Carlton Vic). 2016;21:147.
Vazquez JC, Perez-Padilla R. Effect of oxygen on sleep and breathing in patients with interstitial lung disease at moderate altitude. Respiration. 2001;68(6):584–9.
Article CAS PubMed Google Scholar
Adegunsoye A, Neborak JM, Zhu D, Cantrill B, Garcia N, Oldham JM, et al. CPAP Adherence, Mortality, and progression-free survival in interstitial lung Disease and OSA. Chest. 2020;158(4):1701–12.
Article CAS PubMed PubMed Central Google Scholar
Mediano O, Gonzalez Mangado N, Montserrat JM, Alonso-Alvarez ML, Almendros I, Alonso-Fernandez A, et al. International Consensus Document on Obstructive Sleep Apnea. Arch Bronconeumol. 2022;58(1):52–68.
Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive Airway pressure: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2019;15(2):335–43.
Article PubMed PubMed Central Google Scholar
Randerath W, Verbraecken J, Andreas S, Arzt M, Bloch KE, Brack T et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J. 2017;49(1).
Jacobs SS, Krishnan JA, Lederer DJ, Ghazipura M, Hossain T, Tan AM, et al. Home Oxygen Therapy for adults with chronic lung disease. An official American thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(10):e121–41.
Article CAS PubMed PubMed Central Google Scholar
Hardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D, et al. British thoracic society guidelines for home oxygen use in adults. Thorax. 2015;70(Suppl 1):i1–43.
Srivali N, Thongprayoon C, Cheungpasitporn W. Assessing the impact of continuous positive airway pressure therapy on clinical outcomes in interstitial lung disease patients with coexisting obstructive sleep apnea: a systematic review. Sleep Breath. 2024.
O’Driscoll BR, Howard LS, Earis J, Mak V, British Thoracic Society Emergency Oxygen, Guideline G, Group BTSEOGD. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(Suppl 1):ii1–90.
Pardo A, Cabrera S, Maldonado M, Selman M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir Res. 2016;17:23.
Article PubMed PubMed Central Google Scholar
Minoves M, Hazane-Puch F, Moriondo G, Boutin-Paradis A, Lemarie E, Pepin JL et al. Differential Impact of intermittent vs. sustained hypoxia on HIF-1, VEGF and proliferation of HepG2 cells. Int J Mol Sci. 2023;24(8).
Friscic T, Percic M, Vidovic D, Stajduhar A, Galic E. Impact of CPAP therapy on new inflammation biomarkers. J Clin Med. 2022;11:20.
Carreto-Binaghi LE, Aliouat el M, Taylor ML. Surfactant proteins, SP-A and SP-D, in respiratory fungal infections: their role in the inflammatory response. Respir Res. 2016;17(1):66.
Article PubMed PubMed Central Google Scholar
Wang K, Ju Q, Cao J, Tang W, Zhang J. Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Med (Baltim). 2017;96(23):e7083.
留言 (0)